Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans
Masanari Itokawa(Fujita Health University), Takeo Yoshikawa(RIKEN Center for Brain Science), Shuhei Kato(Tokyo Institute of Psychiatry), Ichiro Sora, Yoko Ogata(RIKEN Center for Brain Science), Kazuhiko Ikeda(Fukushima Medical University), Aizo Furukawa(Tokyo Metropolitan Institute of Medical Science), Makoto Arai(Tokyo Metropolitan Institute of Medical Science), Seiichi Haga(Tokyo Metropolitan Institute of Medical Science), Hiroshi Ujike(Okayama University)
Cited by 74
Related Papers
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
|Nature Genetics|2009|1.3k
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714
Structure of pathological TDP-43 filaments from ALS with FTLD
|Nature|2021|326
Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights
|Cell Reports|2018|264
Brain Cannabinoid CB2 Receptor in Schizophrenia
|Biological Psychiatry|2009|184